Parabilis Medicines, Inc. Common Stock (PBLS) is a publicly traded the market company. As of July 22, 2026, PBLS trades at $31.44 with a market cap of $3.67B and a P/E ratio of 0.00. PBLS moved +2.36% today. Year to date, PBLS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $24.51 to $34.47. Analyst consensus is strong buy with an average price target of $41.75. Rallies surfaces PBLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Parabilis Medicines, Inc. Common Stock (PBLS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PBLS moved +2.36% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $31.44 |
| Market Cap | $3.67B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.47 |
| 52-Week Low | $24.51 |
| Volume | 287.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover PBLS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.75.